XML 58 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
REVENUES BY PRODUCT AND SERVICE CATEGORY AND GEOGRAPHIC REGION AND SIGNIFICANT CONCENTRATIONS
3 Months Ended
Jun. 30, 2014
REVENUES BY PRODUCT AND SERVICE CATEGORY AND GEOGRAPHIC REGION AND SIGNIFICANT CONCENTRATIONS [Abstract]  
REVENUES BY PRODUCT AND SERVICE CATEGORY AND GEOGRAPHIC REGION AND SIGNIFICANT CONCENTRATIONS
NOTE 15.  REVENUES BY PRODUCT AND SERVICE CATEGORY AND GEOGRAPHIC REGION AND SIGNIFICANT CONCENTRATIONS

Revenue Information

The following is a summary of our revenues by product and service category (in thousands):

 
 
Three Months Ended
 
 
 
June 30,
 
Revenues by Product and Service Category
 
2014
  
2013
 
Instruments(1)
 
$
7,594
  
$
8,675
 
Consumables(2)
  
34,286
   
30,599
 
Other products and services(3)
  
5,560
   
3,858
 
Product and service revenues, net
  
47,440
   
43,132
 
Development and licensing revenue
  
37
   
37
 
Total revenues
 
$
47,477
  
$
43,169
 
 

(1)Instruments include chemistry analyzers, hematology instruments, VSpro specialty analyzers and i-STAT analyzers.
(2)Consumables include reagent discs, hematology reagent kits, VSpro specialty cartridges, i-STAT cartridges and rapid tests.
(3)Other products and services include veterinary reference laboratory diagnostic and consulting services.

The following is a summary of our revenues by geographic region based on customer location (in thousands):

 
 
Three Months Ended
 
 
 
June 30,
 
Revenues by Geographic Region
 
2014
  
2013
 
North America
 
$
38,340
  
$
34,652
 
Europe
  
7,284
   
6,552
 
Asia Pacific and rest of the world
  
1,853
   
1,965
 
Total revenues
 
$
47,477
  
$
43,169
 

Significant Concentrations

During the three months ended June 30, 2014 and 2013, one distributor in the United States, MWI Veterinary Supply, accounted for 15% and 23%, respectively, of our total worldwide revenues.

Concentration of credit risk with respect to accounts receivable is primarily limited to certain distributors to whom we make significant sales. One distributor in the United States accounted for 21% and 25% of our total receivable balance at June 30, 2014 and March 31, 2014, respectively.